Kinevant Sciences Is A Clinical Stage Biopharmaceutical Company Based In New Yorkdedicated To Developing Therapies For Rare Inflammatory And Autoimmune Diseasesthe Company Focuses On Addressing Significant Unmet Medical Needs Within The Healthcare Sector Kinevant S Primary Area Of Research Involves Monoclonal Antibodies That Target Specific Inflammatory Pathwaystheir Lead Candidatenamilumabis An Investigational Anti Gm Csf Monoclonal Antibody Aimed At Treating Sarcoidosisan Inflammatory Diseasethe Company Is Actively Engaged In Research Effortsincluding The Resolve Lung Studywhich Evaluated Namilumab For Chronic Pulmonary Sarcoidosiskinevant Sciences Is Committed To Advancing Innovative Treatments For Rare Diseases
No conferences found for this company.
| Company Name | Kinevant Sciences Gmbh |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
